Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 2,873 | 3,223 | 3,223 | N/A |
| Marketable Securities | 2,953 | 2,453 | 2,453 | N/A |
| Other current assets | 158 | 186 | 186 | 0 |
| TOTAL | $5,984 | $5,862 | $5,862 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 391 | 250 | 250 | N/A |
| Other Non-Current Assets | 138 | 123 | 123 | 0 |
| TOTAL | $529 | $373 | $373 | $N/A |
| Total Assets | $6,513 | $6,235 | $6,235 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 127 | 50 | 50 | 0 |
| Accrued Expenses | 239 | 242 | 242 | N/A |
| Other current liabilities | 75 | 67 | 67 | N/A |
| TOTAL | $539 | $410 | $410 | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $251 | $157 | $157 | $N/A |
| Total Liabilities | $790 | $567 | $567 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 32 | 31 | 31 | N/A |
| Retained earnings | -3,593 | -3,572 | -3,572 | N/A |
| Other shareholders' equity | 9,222 | 9,147 | 9,147 | 0 |
| TOTAL | $5,724 | $5,667 | $5,667 | $N/A |
| Total Liabilities And Equity | $6,513 | $6,235 | $6,235 | $0 |